ORAL CORTICOSTEROIDS AND THE LONG-TERM RISK OF CATARACT: A COMPREHENSIVE SYSTEMATIC REVIEW
DOI:
https://doi.org/10.61841/keyzn750Keywords:
Corticosteroid, cataract, oral corticosteroid, glucocorticoids.Abstract
Background: A cataract can lead to visual deterioration, resulting in reduced vision capacity and partial or complete reversible vision loss. The most commonly associated risk factors for cataract include aging, diabetic retinopathy, glaucoma, and some medications such as glucocorticoids. Glucocorticoids are utilized in a variety of disorders, as longand short-term, treatment such as topical ocular steroid usage, allergic rhinitis and inflammatory bowel disease as a result, the chance of cataract may increase and put a significant burden in countries.
The aim: This study aims to show about oral corticosteroids and the long-term risk of cataract.
Methods: By comparing itself to the standards set by the Preferred Reporting Items for Systematic Review and MetaAnalysis (PRISMA) 2020, this study was able to show that it met all of the requirements. So, the experts were able to make sure that the study was as up-to-date as it was possible to be. For this search approach, publications that came out between 2014 and 2024 were taken into account. Several different online reference sources, like Pubmed and SagePub, were used to do this. It was decided not to take into account review pieces, works that had already been published, or works that were only half done.
Result: In the PubMed database, the results of our search brought up 79 articles, whereas the results of our search on SagePub brought up 208 articles, on Google Scholar brought up 26.000 articles. The results of the search conducted for the last year of 2014 yielded a total 25 articles for PubMed, 73 articles for SagePub, and 18.000 articles for Google Scholar. The result based on title screening, a total 2 articles for PubMed, 36 articles for SagePub, and 397 for Google Scholar. In the end, we get a total of 10 papers. We included five research that suitable the criteria.
Conclusion: Using glucocorticoids either as inhaler and/or orally will increase the risk and prevalence of posterior subcapsular cataract and other ocular complications such as glaucoma.
References
Savran O, Suppli Ulrik C. Inhaled Corticosteroid Exposure and Risk of Cataract in Patients with Asthma and COPD: A Systematic Review and Meta-Analysis. J Ophthalmol. 2023;2023:16–8.
Hugosson M, Ekström C. Prevalence and risk factors for age-related cataract in Sweden. Ups J Med Sci [Internet]. 2020;125(4):311–5. Available from: https://doi.org/10.1080/03009734.2020.1802375
Black RJ, Hill CL, Lester S, Dixon WG. The association between systemic glucocorticoid use and the risk of cataract and glaucoma in patients with rheumatoid arthritis: A systematic review and meta- analysis. PLoS One. 2016;11(11):1–15.
Carlson J, McBride K, O’Connor M. Drugs associated with cataract formation represent an unmet need in cataract research. Front Med. 2022;9(August):1–10.
Alsomali AI, Alhajri HM, Aljumaiah R, Alnasser MN, Alabdullah Z. Awareness of the Risk of Chronic Use of Steroid Causing Cataract in Al Ahsa City , Saudi Arabia. 2024;16(1):1–8.
Payal AR, Begum H, Kaçmaz RO, Jabs DA. Risk of Cataract in Intermediate Uveitis. 2022;(January 2020):200–9.
Bamahfouz A, Elmorsy S, Alharbi ER, Bakry SM, Alnemari W. Assessment of the Level of Knowledge and Awareness of the Risk of Chronic Use of Steroids in Causing Cataracts Among the General Population in the Western Region of the Kingdom of Saudi Arabia ( KSA ): A Cross- Sectional Study. 2024;16(1):1–7.
Güçlü ÖA, Ismayılov AS. Ocular Surface, Intraocular Pressure, and Lens Condition in Bronchodilator and Steroid-Treated Patients with Chronic Pulmonary Disease. Med Princ Pract. 2023;32(4–5):288–96.
Price DB, Trudo F, Voorham J, Xu X, Kerkhof M, Jie JLZ, et al. Adverse outcomes from initiation of systemic corticosteroids for asthma: Long-term observational study. J Asthma Allergy. 2018;11:193–204.
Yasir M, Sonthalia S. Corticosteroid Adverse Effects. StatPearls [Internet]. 2019;1–12. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30285357
Mushtaq U, Shaman Ameen B, Nie C, Nechi D, Mazhar IJ, Yasir M, et al. Association Between the Use of Systemic Steroids and Ocular Hypertension as a Side Effect in Pediatric Population: A Systematic Review. Cureus. 2023;15(7):1–10.
Aljebab F, Choonara I, Conroy S. Systematic review of the toxicity of long- course oral corticosteroids in children. PLoS One. 2017;12(1):1–18.
Patel R, Naqvi SA, Griffiths C, Bloom CI. Systemic adverse effects from inhaled corticosteroid use in asthma: A systematic review. BMJ Open Respir Res. 2020;7(1):1–11.
Agarwal A, Ram J. Complicated Cataract. The Uveitis Atlas. 2016;1–5.
Koshi EJ, Young K, Mostales JC, Vo KB, Burgess LP. Complications of Corticosteroid Therapy: A Comprehensive Literature Review. J Pharm Technol. 2022;38(6):360–7.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing
Ninety Nine Publication publishes articles under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This licensing allows for any use of the work, provided the original author(s) and source are credited, thereby facilitating the free exchange and use of research for the advancement of knowledge.
Detailed Licensing Terms
Attribution (BY): Users must give appropriate credit, provide a link to the license, and indicate if changes were made. Users may do so in any reasonable manner, but not in any way that suggests the licensor endorses them or their use.
No Additional Restrictions: Users may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
